CD274 and neoplasm: (38) revealed that tumor-specific CD4+ T cells differentiated into T helper 1 cells and CD4- T cells, in which CD4- T cells are critical for controlling established tumor metastasis and tumor specific-CD4+ T cells have a synergistic therapeutic effect with PD-L1 blockade.